S. 801

Referred to Committee

A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.

Introduced 3/14/2019•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on Finance.

3/14/2019 • Senate

Summary

This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

Introduced in Senate • 3/14/2019

Enter your district to see how this bill affects your community

Topics & Subjects

Policy Area: Health

Advisory bodiesHealth care costs and insuranceHealth information and medical recordsHealth programs administration and fundingMedicaidMedicarePrescription drugs